A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression
Open Access
- 30 July 2012
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (7), e41778
- https://doi.org/10.1371/journal.pone.0041778
Abstract
Although previous meta-analyses have examined effects of antidepressants, psychotherapy, and alternative therapies for depression, the efficacy of these treatments alone and in combination has not been systematically compared. We hypothesized that the differences between approved depression treatments and controls would be small. The authors first reviewed data from Food and Drug Administration Summary Basis of Approval reports of 62 pivotal antidepressant trials consisting of data from 13,802 depressed patients. This was followed by a systematic review of data from 115 published trials evaluating efficacy of psychotherapies and alternative therapies for depression. The published depression trials consisted of 10,310 depressed patients. We assessed the percentage symptom reduction experienced by the patients based on treatment assignment. Overall, antidepressants led to greater symptom reduction compared to placebo among both unpublished FDA data and published trials (F = 38.5, df = 239, pF = 2.17, df = 313, pp = 0.027) and psychotherapy (p = 0.022) alone. The magnitude of symptom reduction was greater with psychotherapies compared to placebo (p = 0.019), treatment-as-usual (p = 0.012) and waiting-list (p<0.001). Differences were not seen with psychotherapy compared to antidepressants, alternative therapies or active intervention controls. In conclusion, the combination of psychotherapy and antidepressants for depression may provide a slight advantage whereas antidepressants alone and psychotherapy alone are not significantly different from alternative therapies or active intervention controls. These data suggest that type of treatment offered is less important than getting depressed patients involved in an active therapeutic program. Future research should consider whether certain patient profiles might justify a specific treatment modality.This publication has 32 references indexed in Scilit:
- Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depressionBehaviour Research and Therapy, 2010
- Acupuncture for depressionEmergencias, 2010
- A comparison of depressed patients in randomized versus nonrandomized trials of antidepressant medication and psychotherapyDepression and Anxiety, 2009
- Does Study Design Influence Outcome?Psychotherapy and Psychosomatics, 2009
- Patients' Depression Treatment Preferences and Initiation, Adherence, and Outcome: A Randomized Primary Care StudyPsychiatric Services, 2009
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyThe New England Journal of Medicine, 2008
- Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsBMJ, 2003
- The dodo bird verdict is alive and well--mostly.Clinical Psychology: Science and Practice, 2002
- Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: A meta-analytic approachClinical Psychology Review, 2001
- An analysis of psychotherapy versus placebo studiesBehavioral and Brain Sciences, 1983